Patents by Inventor Meghan Norris Bradley

Meghan Norris Bradley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11959124
    Abstract: Disclosed are methods and systems for the analysis activity of enzyme disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) in a sample. The methods and systems disclosed herein can be useful for diagnosis of thrombotic thrombocytopenic purpura in a patient.
    Type: Grant
    Filed: November 4, 2020
    Date of Patent: April 16, 2024
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Russell Philip Grant, Christopher Michael Shuford, Meghan Norris Bradley
  • Publication number: 20220091131
    Abstract: Disclosed are methods and systems using liquid chromatography/tandem mass spectrometry (LC-MS/MS and 2D-LC-MS/MS) for the proteomic analysis of genotypes. In certain embodiments, samples used in the analysis comprise dried bodily fluids.
    Type: Application
    Filed: November 8, 2021
    Publication date: March 24, 2022
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Christopher Michael Shuford, Russell Philip Grant, Meghan Norris Bradley, Patricia Louise Miller Holland, Michael Levandoski
  • Patent number: 11199547
    Abstract: Disclosed are methods and systems using liquid chromatography/tandem mass spectrometry (LC-MS/MS and 2D-LC-MS/MS) for the proteomic analysis of genotypes. In certain embodiments, samples used in the analysis comprise dried bodily fluids.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: December 14, 2021
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Christopher Michael Shuford, Russell Philip Grant, Meghan Norris Bradley, Patricia Louise Miller Holland, Michael Levandoski
  • Publication number: 20210062242
    Abstract: Disclosed are methods and systems for the analysis activity of enzyme disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) in a sample. The methods and systems disclosed herein can be useful for diagnosis of thrombotic thrombocytopenic purpura in a patient.
    Type: Application
    Filed: November 4, 2020
    Publication date: March 4, 2021
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Russell Philip Grant, Christopher Michael Shuford, Meghan Norris Bradley
  • Patent number: 10858689
    Abstract: Disclosed are methods and systems for the analysis activity of enzyme disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) in a sample. The methods and systems disclosed herein can be useful for diagnosis of thrombotic thrombocytopenic purpura in a patient.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: December 8, 2020
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Russell Philip Grant, Christopher Michael Shuford, Meghan Norris Bradley
  • Publication number: 20190369116
    Abstract: Disclosed are methods and systems using liquid chromatography/tandem mass spectrometry (LC-MS/MS and 2D-LC-MS/MS) for the proteomic analysis of genotypes. In certain embodiments, samples used in the analysis comprise dried bodily fluids.
    Type: Application
    Filed: May 31, 2019
    Publication date: December 5, 2019
    Inventors: Christopher Michael Shuford, Russell Philip Grant, Meghan Norris Bradley, Patricia Louise Miller Holland, Michael Levandoski
  • Publication number: 20190369113
    Abstract: Disclosed are methods and systems using liquid chromatography/tandem mass spectrometry (LC-MS/MS) for the analysis of endogenous biomarkers isolated from biological samples. In certain embodiments, the samples comprise dried body fluids such as dried plasma.
    Type: Application
    Filed: May 31, 2019
    Publication date: December 5, 2019
    Inventors: Christopher Michael Shuford, Russell Philip Grant, Meghan Norris Bradley, Patricia Louise Miller Holland, Michael Levandoski, Matthew Lee Francis Crawford, Bradley Collier
  • Publication number: 20180163249
    Abstract: Disclosed are methods and systems for the analysis activity of enzyme disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) in a sample. The methods and systems disclosed herein can be useful for diagnosis of thrombotic thrombocytopenic purpura in a patient.
    Type: Application
    Filed: October 11, 2017
    Publication date: June 14, 2018
    Inventors: Russell Philip Grant, Christopher Michael Shuford, Meghan Norris Bradley